TCR validation toward gene therapy for cancer: chapter twenty-one
The speed of T cell receptor (TCR) discovery has been revolutionized by barcode-based TCR sequencing approaches that allow the reconstitution of a T cell's paired alpha and beta TCR chain, and the process of TCR discovery promises to become ever faster and cheaper with the continuing developmen...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Chapter/Article |
| Language: | English |
| Published: |
06 November 2019
|
| In: |
Tumor Immunology and immunotherapy
Year: 2019, Pages: 419-441 |
| DOI: | 10.1016/bs.mie.2019.10.010 |
| Online Access: | Verlag: https://doi.org/10.1016/bs.mie.2019.10.010 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0076687919304124 
|
| Author Notes: | Edward W. Green, Lukas Bunse, Matthias Bozza, Khwab Sanghvi, Michael Platten |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 169577972X | ||
| 003 | DE-627 | ||
| 005 | 20220818051624.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200423s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/bs.mie.2019.10.010 |2 doi | |
| 035 | |a (DE-627)169577972X | ||
| 035 | |a (DE-599)KXP169577972X | ||
| 035 | |a (OCoLC)1341316223 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Green, Edward W. |e VerfasserIn |0 (DE-588)1207577499 |0 (DE-627)169408163X |4 aut | |
| 245 | 1 | 0 | |a TCR validation toward gene therapy for cancer |b chapter twenty-one |c Edward W. Green, Lukas Bunse, Matthias Bozza, Khwab Sanghvi, Michael Platten |
| 264 | 1 | |c 06 November 2019 | |
| 300 | |a 23 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.04.2020 | ||
| 520 | |a The speed of T cell receptor (TCR) discovery has been revolutionized by barcode-based TCR sequencing approaches that allow the reconstitution of a T cell's paired alpha and beta TCR chain, and the process of TCR discovery promises to become ever faster and cheaper with the continuing development single cell analysis techniques. This technological progress has generated an urgent need to develop efficient TCR validation platforms for the rapid and safe clinical translation of TCRs into therapeutic agents. Whereas much attention has in the past focused on CD8-positive cytotoxic T cells recognizing MHC class I presented epitopes, the increasing demand to validate TCRs expressed on neoepitope-reactive CD4 T cells requires the implementation of large-scale T cell activation-based readout assays to complement existing multimer and cytotoxicity-based assays. Here, we present commonly used TCR validation assays, and include detailed guidance on TCR synthesis, delivery, and appropriate experimental control TCRs. We also comment on upcoming methods that hold promise for further speeding the process of TCR validation, hastening the translation of TCRs from the laboratory into the clinic. | ||
| 650 | 4 | |a Cloning | |
| 650 | 4 | |a Cytotoxicity assays | |
| 650 | 4 | |a Luciferase | |
| 650 | 4 | |a NFAT | |
| 650 | 4 | |a RTCA | |
| 650 | 4 | |a TCR | |
| 700 | 1 | |a Bunse, Lukas |d 1988- |e VerfasserIn |0 (DE-588)1051941229 |0 (DE-627)787187399 |0 (DE-576)407600426 |4 aut | |
| 700 | 1 | |a Bozza, Matthias |e VerfasserIn |0 (DE-588)1151463353 |0 (DE-627)1011809087 |0 (DE-576)497767783 |4 aut | |
| 700 | 1 | |a Sanghvi, Khwab |d 1990- |e VerfasserIn |0 (DE-588)1201828864 |0 (DE-627)1685962580 |4 aut | |
| 700 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tumor Immunology and immunotherapy |b First edition |d Cambridge, MA : Elsevier, Academic Press, 2019 |g (2019), Seite 419-441 |h 1 Online-Ressource (xl, 511 Seiten) |w (DE-627)1681635976 |7 nnam |a TCR validation toward gene therapy for cancer chapter twenty-one |
| 773 | 1 | 8 | |g year:2019 |g pages:419-441 |g extent:23 |a TCR validation toward gene therapy for cancer chapter twenty-one |
| 856 | 4 | 0 | |u https://doi.org/10.1016/bs.mie.2019.10.010 |x Verlag |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0076687919304124 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200423 | ||
| 993 | |a BookComponentPart | ||
| 994 | |a 2019 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 60000 |d 62700 |e 60000PP121627780 |e 62700PP121627780 |k 0/60000/ |k 1/60000/62700/ |p 5 |y j | ||
| 998 | |g 1201828864 |a Sanghvi, Khwab |m 1201828864:Sanghvi, Khwab |d 140000 |e 140000PS1201828864 |k 0/140000/ |p 4 | ||
| 998 | |g 1151463353 |a Bozza, Matthias |m 1151463353:Bozza, Matthias |p 3 | ||
| 998 | |g 1051941229 |a Bunse, Lukas |m 1051941229:Bunse, Lukas |d 60000 |d 62700 |e 60000PB1051941229 |e 62700PB1051941229 |k 0/60000/ |k 1/60000/62700/ |p 2 | ||
| 998 | |g 1207577499 |a Green, Edward W. |m 1207577499:Green, Edward W. |p 1 |x j | ||
| 999 | |a KXP-PPN169577972X |e 3631048092 | ||
| BIB | |a Y | ||
| JSO | |a {"person":[{"family":"Green","roleDisplay":"VerfasserIn","given":"Edward W.","display":"Green, Edward W.","role":"aut"},{"given":"Lukas","display":"Bunse, Lukas","role":"aut","roleDisplay":"VerfasserIn","family":"Bunse"},{"roleDisplay":"VerfasserIn","family":"Bozza","display":"Bozza, Matthias","role":"aut","given":"Matthias"},{"given":"Khwab","display":"Sanghvi, Khwab","role":"aut","roleDisplay":"VerfasserIn","family":"Sanghvi"},{"roleDisplay":"VerfasserIn","family":"Platten","given":"Michael","role":"aut","display":"Platten, Michael"}],"physDesc":[{"extent":"23 S."}],"name":{"displayForm":["Edward W. Green, Lukas Bunse, Matthias Bozza, Khwab Sanghvi, Michael Platten"]},"relHost":[{"person":[{"roleDisplay":"HerausgeberIn","family":"Galluzzi","given":"Lorenzo","display":"Galluzzi, Lorenzo","role":"edt"},{"family":"Rudqvist","roleDisplay":"HerausgeberIn","given":"Nils-Petter","role":"edt","display":"Rudqvist, Nils-Petter"}],"relMultPart":[{"recId":"507525221","id":{"issn":["1557-7988","0076-6879"],"zdb":["2221516-5"],"eki":["507525221"]},"title":[{"title_sort":"Methods in enzymology","title":"Methods in enzymology"}],"disp":"Methods in enzymology","pubHistory":["1.1955 -"],"dispAlt":"Methods in enzymology","type":{"bibl":"serial","media":"Online-Ressource"},"origin":[{"publisherPlace":"New York, NY [u.a.]","dateIssuedKey":"1955","dateIssuedDisp":"1955-","publisher":"Elsevier"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"number":["volume 629"],"number_sort":["629"]}}],"physDesc":[{"extent":"1 Online-Ressource (xl, 511 Seiten)"}],"name":{"displayForm":["edited by Lorenzo Galluzzi, Nils-Petter Rudqvist"]},"part":{"pages":"419-441","year":"2019","extent":"23","text":"(2019), Seite 419-441"},"origin":[{"publisherPlace":"Cambridge, MA ; San Diego, CA ; Oxford ; London","dateIssuedKey":"2019","dateIssuedDisp":"2019","editionNo":1,"edition":"First edition","publisher":"Elsevier, Academic Press"}],"type":{"bibl":"edited-book","media":"Online-Ressource"},"language":["eng"],"disp":"TCR validation toward gene therapy for cancer chapter twenty-oneTumor Immunology and immunotherapy","recId":"1681635976","id":{"eki":["1681635976"]},"title":[{"subtitle":"molecular methods","title_sort":"Tumor Immunology and immunotherapy","title":"Tumor Immunology and immunotherapy"}]}],"language":["eng"],"origin":[{"dateIssuedDisp":"06 November 2019","dateIssuedKey":"2019"}],"type":{"media":"Online-Ressource","bibl":"chapter"},"title":[{"title":"TCR validation toward gene therapy for cancer","title_sort":"TCR validation toward gene therapy for cancer","subtitle":"chapter twenty-one"}],"id":{"eki":["169577972X"],"doi":["10.1016/bs.mie.2019.10.010"]},"recId":"169577972X","note":["Gesehen am 23.04.2020"]} | ||
| SRT | |a GREENEDWARTCRVALIDAT0620 | ||